The Journal of Organic Chemistry
Note
+
−1
equiv.). The crude product was purified by flash column
chromatography (cyclohexane/EtOAc, 4:1) to provide 11 as a
white solid in 95% yield (208 mg, 0.47 mmol). H NMR (600
Na] ) 580.1868, found 580.1854 IR ṽ [cm ] = 2962 (w), 2358 (w),
1791 (s), 1718 (m), 1621 (s), 1459 (m), 1393 (m), 1344 (m), 1289
(m), 1176 (m), 1121 (m), 1041 (m), 753 (s), 695 (m). R
(cyclohexane/EtOAc, 4:1) = 0.25 [p-Anisaldehyde]. [α] = +36.9
1
f
2
0
MHz, CDCl ) δ 7.48 (dd, J = 8.2, 1.8 Hz, 1H), 7.37 (d, J = 1.8 Hz,
3
D
1
8
5
3
(
1
1
H), 7.32−7.28 (m, 3H), 7.23 (dd, J = 6.6, 2.9 Hz, 2H), 6.81 (d, J =
.1 Hz, 1H), 6.04 (q, J = 1.4 Hz, 2H), 5.61 (s, 1H), 5.21 (dd, J = 6.9,
.0 Hz, 1H), 5.11 (d, J = 12.1 Hz, 1H), 5.02 (d, J = 12.1 Hz, 1H),
(ρ = 0.95, CH Cl ).
2
2
Benzyl (2S,4S)-2-(tert-butyl)-5-oxo-4-(2-oxo-2-(3-(4,4,5,5-tetra-
methyl-1,3,2-dioxaborolan-2-yl)phenyl)ethyl)oxazolidine-3-car-
boxylate (15). Synthesized following GP-A using 4-carboxylphenyl-
boronic acid pinacol ester (186 mg, 0.75 mmol, 1.5 equiv.). The crude
product was purified by flash column chromatography (cyclohexane/
.46 (dd, J = 16.1, 7.0 Hz, 1H), 3.29 (dd, J = 16.1, 5.1 Hz, 1H), 1.01
s, 9H). 13C{ H} NMR (151 MHz, CDCl ) δ 192.8, 172.2, 155.7,
1
3
52.2, 148.5, 135.3, 131.3, 128.7, 128.6, 128.5, 124.6, 108.1, 108.0,
EtOAc, 4:1) to provide 15 as a white solid in 76% yield (198 mg, 0.38
02.1, 96.3, 68.3, 53.9, 41.7, 37.5, 24.9. HRMS (ESI) [m/z] calculated
1
+
mmol). H NMR (600 MHz, CDCl ) δ 8.31 (s, 1H), 8.03−7.98 (m,
for C H NNaO ([M + Na] ) 462.1520, found 462.1523. IR v
̃
3
2
4
25
7
−
1
[
(
cm ] = 2963 (w), 1791 (s), 1718 (m), 1676 (m), 1604 (m), 1485
s), 1443 (s), 1393 (s), 1345 (m), 1235 (w), 1176 (m), 1110 (s),
2H), 7.47 (d, J = 7.7 Hz, 1H), 7.29−7.27 (m, 3H), 7.23−7.18 (m,
2H), 5.61 (s, 1H), 5.24 (dd, J = 6.7, 5.2 Hz, 1H), 5.11 (d, J = 12.1 Hz,
1H), 4.96 (d, J = 12.1 Hz, 1H), 3.55 (dd, J = 16.3, 6.8 Hz, 1H), 3.44
1
034 (s), 930 (m), 808 (w). 733 (s), 697 (s). R (cyclohexane/
f
2
0
13
1
EtOAc, 4:1) = 0.32 [p-Anisaldehyde]. [α]D = +41.5 (ρ = 0.95,
CH Cl ).
(dd, J = 16.3, 5.2 Hz, 1H), 1.36 (s, 12H), 1.03 (s, 9H). C{ H}
NMR (151 MHz, CDCl ) δ 195.1, 172.2, 155.7, 139.9, 136.0, 135.3,
134.6, 131.0, 128.7, 128.6, 128.5, 128.3, 96.4, 84.4, 68.3, 53.9, 41.9,
2
2
3
Benzyl (2S,4S)-2-(tert-butyl)-4-(2-(2-chlorophenyl)-2-oxoethyl)-
-oxooxazolidine-3-carboxylate (12). Synthesized following GP-A
5
37.6, 25.1, 25.0. HRMS (ESI) [m/z] calculated for C H BNNaO
2
9
36
7
+
−1
using 2-chlorobenzoic acid (117.4 mg, 0.75 mmol, 1.5 equiv.). The
([M + Na] ) 544.2480, found 544.2477. IR ṽ [cm ] = 2974 (w),
crude product was purified by flash column chromatography
2931 (w), 2358 (w), 1793 (s), 1720 (s), 1687 (m), 1482 (m), 1390
(
cyclohexane/EtOAc, 10:1) to provide 12 as a yellow oil in 95%
(m), 1348 (m), 1287 (m), 1140 (m), 1041 (m), 697 (s). R
(cyclohexane/EtOAc, 4:1) = 0.5 [p-Anisaldehyde]. [α]D = +37.1
f
1
20
yield (203 mg, 0.47 mmol). H NMR (600 MHz, CDCl ) δ 7.47 (d, J
3
=
7.7 Hz, 1H), 7.41−7.39 (m, 2H), 7.33 (s, 5H), 7.32−7.28 (m, 1H),
(ρ = 1.14, CH Cl ).
2
2
5
.61 (s, 1H), 5.22 (t, J = 6.1 Hz, 1H), 5.20−5.12 (m, 2H), 3.51−3.48
Benzyl (2S,4S)-2-(tert-butyl)-5-oxo-4-(2-oxo-2-(pyridin-3-yl)-
ethyl)oxazolidine-3-carboxylate (16). Synthesized following GP-A
using nicotinic acid (92.25 mg, 0.75 mmol, 1.5 equiv.). The crude
product was purified by flash column chromatography (cyclohexane/
1
3
1
(m, 2H), 0.97 (s, 9H). C{ H} NMR (151 MHz, CDCl ) δ 197.4,
3
1
72.1, 155.6, 138.5, 135.3, 132.4, 131.3, 130.7, 130.0, 128.8, 128.7,
128.6, 127.2, 96.4, 68.5, 53.7, 45.8, 37.6, 24.9. HRMS (ESI) [m/z]
+
calculated for C H ClNNaO ([M + Na] ) 452.1215, found
EtOAc, 4:1) to provide 16 as a yellow oil in 45% yield (110 mg, 0.28
23
24
5
−
1
1
4
1
1
52.1235. IR v
̃
[cm ] = 2968 (w), 1791 (s), 1716 (s), 1589 (s),
mmol). H NMR (400 MHz, CDCl
3
) δ 9.11−9.08 (m, 1H), 8.80 (dd,
392 (m), 1345 (m), 1284 (m), 1176 (m), 1120 (m), 1076 (m),
040 (m), 976 (m), 757 (m), 697 (m), 697 (s), 633 (m). R
J = 5.0, 1.7 Hz, 1H), 8.19 (dt, J = 8.0, 1.9 Hz, 1H), 7.44 (ddd, J = 8.0,
4.9, 0.8 Hz, 1H), 7.32−7.28 (m, 3H), 7.25−7.22 (m, 2H), 5.62 (s,
1H), 5.21 (dd, J = 6.9, 5.0 Hz, 1H), 5.07 (q, J = 12.0 Hz, 2H), 3.54
(dd, J = 16.4, 6.9 Hz, 1H), 3.39 (dd, J = 16.4, 5.0 Hz, 1H), 1.01 (s,
f
2
0
(
(
cyclohexane/EtOAc, 4:1) = 0.45 [p-Anisaldehyde]. [α] = +47.2
ρ = 1.03, CH Cl ).
D
2
2
1
3
1
Benzyl (2S,4S)-4-(2-(2-acetoxyphenyl)-2-oxoethyl)-2-(tert-butyl)-
9H). C{ H} NMR (101 MHz, CDCl ) δ 193.6, 171.9, 155.6, 153.3,
3
5
-oxooxazolidine-3-carboxylate (13). Synthesized following GP-A
149.1, 136.2, 135.0, 132.0, 128.8, 128.8, 128.6, 124.1, 96.5, 68.6, 53.6,
using 2-acetoxybenzoic acid (135 mg, 0.75 mmol, 1.5 equiv.). The
42.1, 37.6, 24.9. HRMS (ESI) [m/z] calculated for C H N O ([M
2
2
25
2
5
+
−1
crude product was purified by flash column chromatography
+ Na] ) 397.1757, found 397.1758. IR ṽ [cm ] = 3035 (w), 1790
(
cyclohexane/EtOAc, 10:1) to provide 13 as a yellow oil in 92%
(s), 1719 (m), 1480 (m), 1392 (m), 1343 (m), 1285 (m), 1176 (m),
1
yield (208 mg, 0.45 mmol). H NMR (600 MHz, CDCl ) δ 7.67 (dd,
1120 (s), 1040 (m), 1020 (m), 779 (m), 698 (m). R (cyclohexane/
EtOAc, 1:1) = 0.4 [p-Anisaldehyde]. [α] = +42.3 (ρ = 1.04,
3
f
2
0
J = 7.8, 1.7 Hz, 1H), 7.56−7.52 (m, 1H), 7.33−7.27 (m, 5H), 7.15
D
(
dd, J = 8.1, 1.1 Hz, 1H), 5.60 (s, 1H), 5.19 (dd, J = 7.0, 4.8 Hz, 1H),
.15 (d, J = 12.1 Hz, 1H), 5.06 (d, J = 12.1 Hz, 1H), 3.47 (dd, J =
6.7, 7.0 Hz, 1H), 3.31 (dd, J = 16.7, 4.8 Hz, 1H), 2.31 (s, 3H), 0.98
CH Cl ).
2
2
5
1
Benzyl (2S,4S)-2-(tert-butyl)-4-(2-(1,3-dimethyl-1H-pyrazolo[3,4-
b]pyridin-5-yl)-2-oxoethyl)-5-oxooxazolidine-3-carboxylate (17)
and Benzyl (2S,4S)-2-(tert-butyl)-4-(2-(4-chloro-1,3-dimethyl-1H-
pyrazolo[3,4-b]pyridin-5-yl)-2-oxoethyl)-5-oxooxazolidine-3-car-
boxylate (17′). Synthesized following GP-B using 4-Chloro-1,3-
dimethylpyrazolo[3,4-b]pyridine-5-carboxylic acid (169 mg, 0.75
mmol 1.5 equiv.), and irradiating for 48 h. The crude product was
purified by flash column chromatography (cyclohexane/EtOAc, 2:1)
to provide 17 a yellow foam in 39% (98 mg, 0.20 mmol) and 17′ as a
s, 9H). 13C{ H} NMR (151 MHz, CDCl ) δ 194.6, 172.1, 169.4,
1
(
3
1
1
55.6, 149.2, 135.4, 133.6, 130.5, 129.9, 128.8, 128.7, 128.5, 126.2,
24.1, 96.3, 68.4, 53.5, 44.9, 37.6, 24.9, 21.2. HRMS (ESI) [m/z]
+
calculated for C H NNaO ([M + Na] ) 476.1681, found 476.1680.
25
27
7
−
1
IR v
346 (m), 1286 (m), 1177 (w), 1120 (m), 1041 (m), 909 (s), 7534
m), 697 (s), 503 (s). R (cyclohexane/EtOAc, 4:1) = 0.37 [p-
̃
[cm ] = 2965 (w), 2875 (m), 1791 (m), 1718 (m), 1603 (s),
1
(
f
2
0
yellow solid in 18% yield (45 mg, 0.10 mmol). Spectroscopic data for
Anisaldehyde]. [α]D = +41.5 (ρ = 1.01, CH Cl ).
2
2
1
1
7: H NMR (600 MHz, CDCl ) δ 9.05 (d, J = 2.0 Hz, 1H), 8.49 (d,
Benzyl (2S,4S)-2-(tert-butyl)-4-(2-(3-(5-(2-fluorophenyl)-1,2,4-ox-
3
J = 2.0 Hz, 1H), 7.23 (q, J = 2.9 Hz, 3H), 7.19 (dd, J = 6.8, 3.1 Hz,
2H), 5.64 (s, 1H), 5.26 (dd, J = 6.8, 5.2 Hz, 1H), 5.11−5.01 (m, 2H),
4.11 (s, 3H), 3.59 (dd, J = 16.0, 6.8 Hz, 1H), 3.43 (dd, J = 16.0, 5.2
adiazol-3-yl)phenyl)-2-oxoethyl)-5-oxooxazolidine-3-carboxylate
(
14). Synthesized following GP-A using 3-[5-(2-fluorophenyl)-1,2,4-
oxadiazol-3-yl] benzoic acid (213 mg, 0.75 mmol, 1.5 equiv.). The
1
3
1
crude product was purified by flash column chromatography
Hz, 1H), 2.59 (s, 3H), 1.04 (s, 9H). C{ H} NMR (151 MHz,
CDCl ) δ 193.2, 172.0, 155.7, 152.2, 149.5, 143.2, 135.0, 130.8, 128.7,
128.6, 128.5, 125.1, 114.8, 96.5, 68.5, 54.0, 42.0, 37.6, 33.9, 24.9, 12.6.
HRMS (ESI) [m/z] calculated for C25 NaO ([M + Na]+)
[cm ] = 2961 (s), 2926 (s), 1790
(cyclohexane/EtOAc, 4:1) to provide 14 as a yellow oil in 87%
3
1
yield (243.7 mg, 0.44 mmol). H NMR (400 MHz, CDCl ) δ 8.69 (t,
J = 1.7 Hz, 1H), 8.40 (dt, J = 7.8, 1.4 Hz, 1H), 8.24 (ddd, J = 7.8, 7.0,
3
H
N
28
4
5
−
1
1
.8 Hz, 1H), 8.09−8.03 (m, 1H), 7.62 (t, J = 7.8 Hz, 2H), 7.26 (t, J =
487.1957, found 487.1952. IR ṽ
1
.3 Hz, 4H), 5.64 (s, 1H), 5.27 (dd, J = 6.8, 5.1 Hz, 1H), 5.16−4.99
(w), 1719 (w), 1678 (w), 1599 (w), 1564 (m), 1520 (m), 1478 (m),
1392 (w), 1281 (w), 1177 (w), 1121 (m), 1041 (w), 983 (w), 748
(
m, 2H), 3.61 (dd, J = 16.4, 6.8 Hz, 1H), 3.49 (dd, J = 16.4, 5.1 Hz,
1
3
1
1
H), 1.04 (s, 9H). C{ H} NMR (101 MHz, CDCl ) δ 194.3, 173.3
(m), 697 (w), 578 (m), 503 (m), 456 (m), 428 (m). R (cyclohexane/
EtOAc, 1:1) = 0.33 [p-Anisaldehyde]. [α]D = +40.1 (ρ = 0.92,
3
f
3
1
20
(d, J
= 4.4 Hz), 172.1, 168.1, 162.3 (d, J
= 260.8 Hz), 155.7,
= 8.6 Hz), 132.3, 131.1, 130.8, 129.6,
C−F
C−F
3
1
1
3
6
37.1, 135.2, 135.0 (d, J
28.7, 128.7, 128.5, 127.8 (d, J
.8 Hz), 117.5 (d, J
8.5, 53.8, 42.0, 37.6, 24.9. F{ H} NMR (376 MHz, CDCl ) δ
CH Cl ).
C−F
2 2
3
3
1
= 5.0 Hz), 127.4, 124.9 (d, J
=
Spectroscopic data for 17′: H NMR (400 MHz, CDCl ) δ 8.67 (s,
C−F
C−F
3
2
3
= 20.9 Hz), 112.8(d, J
= 11.3 Hz), 96.5,
1H), 7.40−7.29 (m, 1H), 7.27 (tdd, J = 4.6, 3.4, 2.0 Hz, 4H), 5.63 (s,
1H), 5.23 (dd, J = 6.9, 5.4 Hz, 1H), 5.14 (d, J = 1.0 Hz, 2H), 4.07 (s,
3H), 3.60 (dd, J = 16.3, 6.9 Hz, 1H), 3.53 (dd, J = 16.3, 5.5 Hz, 1H),
C−F
C−F
1
9
1
3
−
108.1. HRMS (ESI) [m/z] calculated for C H FN NaO ([M +
31 28 3 6
8
453
J. Org. Chem. 2021, 86, 8448−8456